Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Sufentanil Ropivacaine

Research Leaders

10 sponsors active, led by National Cheng-Kung University Hospital

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown2
Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Sufentanil Ropivacaine1
  • Traditional Ultrasound Scan1
  • Healthy Lifestyle Advise1
  • Autofuse System1
  • Exercise Program1

Active Sponsors

  • National Cheng-Kung University Hospital1
  • Clínica Zuatzu de San Sebastián1
  • Universidad Politecnica de Madrid1
  • Hospital Universitario de Torrejón, Madrid1
  • First Affiliated Hospital of Jinan University1

Top Investigators

Related Conditions

  • Intrauterine Infection1
  • Pregnancy Complications1
  • Maternalfetal Relations1
  • Pregnancy High Risk1
  • Labor Pain1

Activity Timeline